AVISTA wishes you a happy Chinese New Year! May the Year of the Rat bring you good health and good fortune!
 
<img src="../../../../../uploads/AVISTA_CNY_Greetings_2020_c95d2827d4.png" width="700" />

stock-photo-cheers-people-celebrate-and-raise-glasses-of-wine-for-toast-group-of-man-and-woman-cheering-with-1573948762

Chinese New Year Greetings from AVISTA Group

Congratulations to Fujian Haixi Pharmaceutical Co., Ltd. (2637.HK) on its successful Listing on the Mainboard of HKSE on 20 Oct 2025
Fujian Haixi Pharmaceutical Co., Ltd. (“Haixi Pharmaceutical”) is a commercial-stage pharmaceutical company that integrates R&amp;D, production and sales capacities, with a pipeline of innovative drug candidates. Haixi Pharmaceutical has a diversified product portfolio and pipeline in the largest and fastest growing therapeutic areas in China. Haixi Pharmaceutical’s commercialized product portfolio primarily consisted of generic drugs for digestive system diseases, cardiovascular system diseases, endocrine system diseases, nervous system diseases and inflammatory diseases.
With regard to this listing application, AVISTA Group is honored to be engaged in providing ESG advisory services, valuation services in relation to the financial asset and investment property.
Congratulations again Fujian Haixi Pharmaceutical Co., Ltd. (2637.HK) on its successful listing. The issue price of the shares is HKD86.4 per share, and the amount of funds raised is 993.6 million HKD.
<img src="../../../../../uploads/Slide1_79059e180b.JPG" alt="" width="960" height="720" />

banner1

Congratulations to Fujian Haixi Pharmaceutical Co., Ltd. (2637.HK) on its Successful Listing

Beijing Yunji Technology Co., Ltd. (the “Yunji”) is a leading hospitality robotic-based AI-empowered technology company. Yunji primarily offers robots and functional kits, complemented by services under AI digitalization system. From robots that interact with the physical world to AI digitalization system that streamline decision-making, Yunji delivers adaptive and scalable products and services to its customers.
With regard to this listing application, AVISTA Group is honored to be engaged in providing valuation services in relation to share-based compensation and total equity value.
Congratulations again Beijing Yunji Technology Co., Ltd. (2670.HK) on its successful listing. The issue price of the shares is HKD 95.6 per share, and the amount of funds raised is HKD 659.6 million.

Congratulations to Beijing Yunji Technology Co., Ltd.(2670.HK) on its successful Listing on the Mainboard of HKSE on 16 Oct 2025

Congratulations to Shanghai Zhida Technology Development Co., Ltd. (2650.HK) on its successful Listing on the Mainboard of HKSE on 10 Oct 2025
Shanghai Zhida Technology Development Co., Ltd. was founded in 2010. It is a global leading enterprise in new energy vehicle charging and green energy digital technology, dedicated to taking "charging" as an entry point to promote new energy vehicles and green energy into families around the world, and contributing to the sustainable development of mankind. Its product portfolio includes smart home electric vehicle chargers and accessories, electric vehicle charging robots, EMS solutions, and pipeline products.
With regard to this listing application, AVISTA Group is honored to be engaged in providing valuation services in relation to financial instruments, financial assets and impairment of long-term assets.
Congratulations again Shanghai Zhida Technology Development Co., Ltd. (2650.HK) on its successful listing. The issue price of the shares is  HKD66.92per share, and the amount of funds raised is HKD400.12 million.<img src="../../../../../uploads/EN_20003e37c2.JPG" alt="" width="960" height="720" />